HK-based Insilico Medicine raises capital, brings Series D funding to $95m

HK-based Insilico Medicine raises capital, brings Series D funding to $95m

Photo by Hal Gatewood on Unsplash

11 August, 2022

352Air AI Aramco Ventures Insilico Medicine Prosperity7 Ventures

Printed by Unregistered user on Sun, 14 Dec 2025 07:48:22 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

HK-based Insilico closes $60m & 33 more deal updates from Greater China worth $1.6b

Venture Capital

Chinese AI drug discovery startup XtaIPi secures $400m co-led by OrbiMed, HOPU

Read more from Greater China

Editor’s Take: The Week That Was—Dec 8-13

JD.com pledges $3.12b housing support for delivery riders